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ABSTRACT 
Recent inves tiga tions clarifying the monoalninergic influences 
on sympathetic preganglionic neurons in the cat have allowed a 
dh4 ect assessment of the effects of narcotic analgesics and anta-
gonists on central transmission. Intravenous morphine, metha-
done, meperidine or codeine produced an immediate and sustained 
depression of discharges evoked from these spinal sympathetic 
neurons. The potency ratios for production of similar degrees of 
depression by these four agents compared favorably to the potency 
ratios reported for equianalgesic doses. The depression appeared 
to be specific in ~hat it was rapidly reversed by very low doses of 
naloxone or nalorphine and that a non-analgesic stereoisomer re-
lated to these drugs produced qualitatively different effects on the 
sympathetic preganglioniC neurons. The depression of these neu-
rons offers an adequate and sufficient mechanism to account for 
the centrally mediated vasodepressor effect produced by morphine 
and other narcotic analgesics. The pharmacological characteriza-
tion of the morphine and naloxone actions strongly suggests that 
morphine functions as a 5-HT agonist in this system, while nalo-
xone can both block 5 -HT receptors and also stimulate these 
spinal neurons. The significance of these findings relative to 
other acute and chronic effects of the narcotic analgesics are 
discussed. 
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The mvol vement of norepinephrine (NE) and 5 -hydroxy-
tryptamine (5-HT) in the central actions of the narcotic analgesics 
has been amply demonstrated 13,52, 87. However, the exact nature 
and extent of Inonoamine participation remains unclear. To date, 
the vast majority of studies have been concerned \vith correlations 
between the gross physiological effects of these drugs and major 
alterations in the concentrations of the putative central transmitters. 
Relatively few studies have attempted to assess directly the ac-
tions of the narcotics on discrete, yet functional NE or 5-HT com-
ponents of the central nervous system. 
Current developments in understanding the role of endogen-
OllS monoamines in the activity of sympathetic preganglionic 
neurons suggest that these neurons could serve as a model system 
for delineating the mechanisms of action of drugs affecting central 
NE and 5 - HT transmission. Histochemical and anatomical studies 
have shown that these preganglionic neurons, with cell bodies loea-
ted in the intermedolateral columns of the spinal cord, receive a 
rich supply of NE and 5-HT terminals from neurons originating in 
the vasomotor ~enters of the caudal medulla oblongata 16,29,95. 
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Electrophysiological and pharmacological investigations have dem-
onstrated that the NE neurons are excitatory and the 5 - HT neurons 
are inhibitory to the sympathetic preganglionic neurons 28,34,66 • 
By monitoring evoked discharges from these preganglionic neurons, 
coupled with the appropriate use of monOaJnille precursors and 
blocking agents, drug actions mediated through the NE or 5 - HT 
synapses can be assessed and characterized. 
This paper describes the effects of several narcotic analge-
sics and related compounds on activity evoked from sympathetic 
preganglionic neurons. The experiments were conducted in unanes-
thetized spinal cats to confine the sUe of drug action to synapses at 
the spinal level. The narcotics consistently depressed evoked 
sympathetic activity, an effect that could be rapidly antagonized by 
naloxone or nalorphine. Characterization of the effect of morphine 
on these neurons not only suggests its site of action in this system 
but also offers a mechanism that can adequately account for the 




Results were obtained from 44 adult cats of either sex 
wei.ghing bet\veen 2 .1 and 5 .8 kg. During brief ether anesthes ia 
a tracheal caMula was placed, both COlnmon carotid arteries were 
ligated (one of which was cannulated for continuous monitoring of 
arterial pressure) and the vertebral arteries were clamped and oc-
cluded at C2. Anesthesia was discontinued after the spinal eord 
was transected at Cl. Ventilation was maintained with a positive 
pressure respirator adjusted to hold the end expiratory CO2 con-
centration bet\veen 4 and 5% (Spineo Medical Gas Analyzer). Ar-
terial pressure usually stabilized between 70 and 85 mm Hg 
followjng spinal transection. In the few experiments in which 
blood pressure tended to fall below this level, adequate perfus ion 
was maintained by wrapping the hind limbs and abdomen with an 
elastic bandage to reduce peripheral pooling of blood and by intra-
venous administration of small volumes (5 to 10 ml) of 10% dextran-
40. Body temperature was monitored and maintained in the range of 
36 to 38°C by an automatically controlled heating plate. A 
peripheral vein, usually the left cephalic, was cannulated for 
administration of drugs. Gallamine triethiodide (Flaxedil) was 
administered as needed to provide muscle paralysis throughout 
the experiment. 
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The left thoracic sympathetic preganglionic rami commun-
icantes and intercostal nerves of segments T2, T3, and T 4 were 
approached by a dorsal midline incision, reflection of the skin to 
the left, and removal of overlying muscle. The proximal portions 
of ribs 2, 3, and 4 and adjacent intercostal muscles were removed . 
. Care was taken to leave the parietal pleural membrane intact to 
serve as the floor of the recording pool. An ipsilateral pneun1o-
thorax and a rigid blunt retainer positioned against the exposed 
parietal pleural membrane minimized respiratory movement in 
the vicinity of the exposed nerves. 
Dissection was continued under a binocular dissecting micro-
scope (3-25 magnification). Intercostal nerves were sectioned 
approximately 20 mm distal to the vertebral column and were dis-
sected free of adjacent tissue to a point just proximal to the sym-
pathetic trunk. The sympathetic preganglionic rami were identified 
by their location and appearance, their distal entry into the sympa-
thetic chain or gangion, and their proximal juncture with 
appropriate spinal nerves. The intercostal nerves and pregang-
lionic rami were then covered with warm rnineral oil. The rami 
were carefully cleaned of remaining connective tissue between 
their nlerger with the sympathetic trunk and their juncture with a 
corresponding spinal nerve; rami were then sectioned proximal 
to the sympathetic chain. 
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In experiments depending upon intraspinal stimulation, a 
dorsolaterallanlinectonlY was performed to expose the spinal cord 
at either the C2 and C3 or the CS and C6 segments. The dura 
was opened and reflected to expose the dorsal roots which were 
sectioned distally and displaced medially. This exposed dorso-
lateral surface of the spinal cord was covered with warm mineral 
oil. 
Recording and stimulating procedures 
Evoked sympathetic discharges were recorded with a bipolar 
silver-wire electrode from two of the three exposed sympathetic 
preganglionic rami. Evoked responses were amplified (Tektronix 
2A61; frequency response 6-600 Hz) and displayed on a dual-beam 
oscilloscope for continuous monitoring. Evoked activity was quan-
titated on-line by integrating the area above baseline of 16 or 32 
6 
consecutive responses with a signal averaging computer (Nicolet 
1072).. Photographs of the analog computer output and representa-
tive individual discharges served as permanent records for the 
complete cours e of each experiment. 
Sympathetic preganglionic neurons receive excitatory input, 
both from the periphery, through small myelinated afferent fibers 
in the intracostal spinal nerves 27,34, and from supraspinal cen-
ters via tracts descending in the dorsolateral funiculus of the 
spinal cord 41, 66. Both pathways were utilized in the present 
study to evoke sympathetic preganglionic discharges. Fig. 1 pre-
sents schematic representations of the relevant structures involved 
in the peripherally activated spinal reflex pathway (~) and in the 
centrally activated intraspinal pathway (B). 
Stimulation of one of the freed intercostal nerves with su-
pramaximal rectangular pulses (0.2 msec) delivered through bi-
polar silver-wire electrodes from an isolated stimulator (Devices, 
Mark IV) at a frequency of 15/min evoked maximal sympathetic dis-
charges. Reflex responses were evoked either within the same 
segment or from one or two segments distant. 
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Activation of the thoracic sympathetic preganglionic neurons 
through the intraspinal patll\vay (B of Fig. 1) was produced by 
stimulating descending tracts in the dorsolateral funiculus of the 
cervical spinal cord with bipolar tungsten n1icroelectrodes (tip 
e>"''''Posure, 25 ll; 3-9 Mohm; separation, 1 mm). The electrodes, 
held in a micromanipulator, were oriented to enter the spinal 
cord vertically in the sagittal plane. Maximal responses were 
evoked with biphasic pulses (0.2 msec) at a frequency of 6/min 
and a stimulus intensity between 100 and 150 llA. Electrodes were 
positioned under microscopic control to provide thE: largest syrn-
pathetic discharges upon stimulation (DeVices, Mark IV) at inten-
sities just above threshold; the intensity was then raised to evoke 
maximal responses. The use of biphasic pulses and a low rate of 
stinlulation conferred good stability of responses for many hours. 
In all experiments, a digital master control timing unit (Devices, 
Digitimer) was used to trigger stimulation and recording equipment. 
Experimental procedure 
A minimum of five hours elapsed between spinal cord tran-
section and the start of recording. During a control period of at 
least one hour prior to drug administration, evoked responses 
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were sampled to assess the stability of the preparation and to 
generate data from which to calculate a mean control response 
and its variance. In the absence of drug treatment, evoked sym-
pathetic discharges routinely rCfllained within ± 2 Standard Devia-
tions of the mean control value for many hours. Therefore, 
changes occurring after drug adn1inistration were considered sig-
nificant when consecutive readings fell outside this range. 
Following drug administration, evoked activity was sanlpled 
at 5 or 10 min intervals, depending upon the rapidity of drug effect 
and the tiIne required to make nleasurements. Absolute sizes of 
evoked discharges generated by the averaging computer were con-
verted to percentages of the mean control value to standardize 
data for comparison among different experiments. The duration 
of individual experiments depended upon the physiological stability 
of the animal and the time required to complete the experimental 
procedures. Some experiments required up to 15 hours following 
cord transection for completion. 
Although sorne quantitative differences among individual 
experiments were noted, drug effects were generally qualitatively 
consistent and variations were minor. Some of the variability 
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among individual experinlents may have been due to relative dif-
ferences in sensitivity or the proportion of preganglionic neurons 
available for discharge. 
With the exception of parachlorophenylalanine (PCPA), all 
drugs were administered intravenously. PCPA was suspended in 
water with the aid of a small amount of Tween-80 and was injected 
intraperitoneally. D, L-S- HTP was dissolved in warm, normal 
saline at a concentration of 10 mg/mI. All other drug solutions 
were prepared with distilled water or normal saline or comlner-
cially available parenteral forms were used. 
RESULTS 
Drug effects on evoked sympathetic activity 
Morphine. The effects of low dos es of morphine SO 4 on 
activity evoked fron1 sympathetic preganglionic neurons were 
assessed in spinal cats. At doses of 0.5, 1, or 2 mg/kg, morphine 
consistently produced marked depression of transmission through 
either the spinal reflex (Fig. 2A) or the intraspinal pathway 
(Fig. 2B). The onset of depression was rapid, became significant 
within 5 min, and reached a maximum within 20-30 min. Although 
the full duration of the depression was not established, little or 
no recovery occurred within 3 hrs. and only partial recovery was 
observed in several ex-periments that were followed up to 5 1/2 hrs. 
Responses to the same dose of morphine were somewhat 
variable among different experiments, but the degree of depression 
was generally dose-dependent. Although the effects of small doses 
of morphine were usually additive, little or no further depression 
could be produced by doses in excess of 2 mg/kg. The minimum 
effective dose of morphine appeared to be between 0.2 and 0.3 
mg/kg; 0.25 mg/kg produced only marginal reductions in discharg-
es evoked through the intraspinal pathway which was significantly 
11 
more sensitive than the reflex pathway to depression by morphine 
(p < 0.05). Intraspinally evoked responses were reduced by an 
average of 43.2% (S. E., ± 4.5%; N = 14) by 1 mg/kg of morphine, 
whereas the same dose reduced spinal syrnpathetic reflexes by an 
average of only 27 .5% (S. E., ± 4.0%; N = 6). 
Naloxone. Morphine-induced depression of sympathetic dis-
charges evoked by either pathway was rapidly and completely an-
tagonized by very small doses of naloxone Hel (Fig. 2). The 
effects of 1 or 2 mg/kg of rnorphine were completely reversed by 
10 or 20 Ilg/kg of naloxone. The ratio between the dose of naloxone 
required for complete antagonism and the dose of morphine given 
was about 1:100. Sublnaximal doses of naloxone that only partially 
reversed the depression by morphine were additive. Antagonism 
by full doses of naloxone was apparent within several minutes and 
total reversal of depression was usually achieved within 10 min. 
Following reversal of morphine-induced depression by naloxone, 
evoked responses were maintained at or above control levels for 
1-2 hrs before depression gradually intervened. Upon its reappear-
ance this secondary morphine depression was equally susceptible 
to naloxone reversal, indicating that the duration of action of this 
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antagonist was shorter than that of Inorphine. Prior adminis-
tration of an appropriate dose of naloxone was also effective in 
preventing depression by morphine, but the antagonism was sur-
mountable. 
In approximately two-thirds of the experiments, antagonism 
of the depressant effect of morphine by naloxone produced an en-
hancement of evoked sympathetic responses by as much as 30% 
above control levels (Fig. 2). This enhancement was unrelated 
to the initial degree of depression by morphi.ne or to the interval 
between administration of morphine and naloxone. Naloxone, 
alone and in small doses, frequently, but not consistently, caused 
an increase in evoked preganglionic activity to as much as 
130-150% of control values; enhancement was maintained vlith 
gradual decrement for up to 2 1/2 hr. The apparent excitatory 
effect of naloxone, either alone or after morphine, occurred with 
about the same frequency and to about the same degree in respon-
ses evoked by either pathway. Further analysis of this effect of 
naloxone is presented below ... 
Nalorphine. A second narcotic antagonist, nalorphine Hel, 
was tested in several experiments for its ability to counteract the 
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depressant effect of 1 mg/kg of morphine on evoked sympathetic 
discharges. Depression was readily antagonized by 200 J-lg/kg of 
nalorphine, responses being restored to control values within 
10 min and maintained for more than I hr. The effects of nalor-
phine Vlere not characterized further. 
Methadone, meperidine and codeine. The effects of several 
other narcotic analgesics on activity evoked from sympathetic 
preganglionic neurons were determined for comparison with mor-
phine. As illustrated in A, Band C of Fig. 3, methadone HCl 
(l mg/kg), meperidine HCl (10 mg/kg), and codeine PO 4 (12 mg/kg) 
each produced a significant reduction in sympathetic responses 
evoked by stimulation of the intraspinal pathway. The depression 
produced by each of the three drugs was obvious within minutes, 
had reached a maximum by 15 - 20 min, and was stable at that re-
duced level for at least 1 hr e Although depression was consistently 
produced by each agent, some variability in the intensity of effect 
was noted among different experiments. In all experiments, nalo-
xone (10-20 J-lg/kg) promptly reversed the depression induced by 
each narcotic and frequently caused a transient increase in evoked 
activity above control values. 
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The effects of these narcotic analgesics on evoked sympathe-
tic activity were qualitatively similar to those observed for mor-
phine. The time required for onset and full development of. 
depression and the susceptibility of that depression to naloxone 
antagonism were comparable for all four agents. The doses re-
quired for equivalent effect provided the major difference in the 
profile of action by these drugs. Although 1 mg/kg of rnethadone 
usually produced a reduction commensurate with that seen with the 
same dose of morphine, production of a corresponding degree of 
depression by meperidine and codeine required 10-12 tinles that 
alnount. These differences in potencies, however, compare fav-
orab1y to the ratios reported by other investigators for equianal-
gesic doses in both man and animals 53,65 . 
Dextromethorphan. Dextramethorphan is the d - isomer of a 
codeine analog of levorphanol. As such, it is structurally related 
to the narcotic analgesics but is devoid of analgesic, euphoric and 
addictive properties 42. At low doses an antitussive action is its 
most prominent central effect; however, larger doses can produce 
generalized eNS depression 10, 42. Dextromethorphan HBr was 
studied with the intention of further defining the mechanism 
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mediating the action of the narcotic analgesics on evoked sympa-
thetic activity. Prelinlinary experiments showed intravenous 
dextromethorphan to have a serious vasodepressor action, an ef-
fect that could be prevented by prior treatment with pyrilamine 
maleate. Pyrilamine alone had no effect on evoked responses and 
did not alter the actions of morphine or naloxone. 
Fig. 3D shows a representative experiment in which intra-
spinally evoked discharges were modestly reduced by the admin-
istration of 5 mg/kg of dextromethorphan. At this dose, the degree 
of depression was variablE; ranging from 20-40%. Its onset was 
notably less rapid than that routinely observed after morphine and 
the other narcotic analgesics. The reduction in evoked activity 
produced by dextromethorphan could not be revers ed by naloxone. 
As illustrated in Fig. 3D, the depression produced by 5 mg/kg re-
roained relatively unchanged for up to 3 hrs despite an additional 
5 mg/kg dose or the administration of 40 IJg/kg of naloxone. 
In the cat, a selective antitussive action is obtained at doses 
of dextrolnethorphan in the range of 0.25 to 0.50 mg/kg; slightly 
higher doses produce a more generalized eNS depression10 . The 
characteristics of the dextromethorphan effect on evoked 
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sympathetic activity indicate that it is different than that produced 
by the narcotic analgesics and may represent this non-selective 
depression. The observed differences suggest that the action of the 
analges ic is Olners on sympathetic preganglionic neurons is struc-
turally selective. 
Pharmacological characterization of the morphine effect and 
naloxone antagonism 
The bulbospinal serotonergic and noradrenergic neurons 
terminating in lateral colum.lls of the thoracic spinal cord exert 
respective inhibitory and excitatory influences on sympathetic 
preganglionic neurons 28,34,66. The intraspinally evoked respon-
ses referred to in this study are evoked by stimulation of the 
descending axons of these noradrenergic neurons in the cervical 
spinal cord 28,66. The pathway involved in spinal reflex responses, 
h " "" 16 Th bi!" f owever, contams no monoammerglc neurons. e a Ity 0 
the narcotic analgesics to depress activity in both pathways, cannot, 
therefore, be explained by postulating an interference with nor-
adrenergic transmission. Of the known synaptic mechanisms 
influencing sympathetic preganglionic neuron responses, only an 
action involving stimulation of inhibitory 5 - HT receptors could 
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account for this depression 28. Accordingly, a series of experi-
ments were conducted to assess the role of S-HT in the morphine-
induced depression of the sympathetic preganglionic neurons. In 
addition, aspects of the naloxone antagonism of morphine were 
investigated .. 
PCPA. To assess whether endogenous S-HT was necessary 
for the action of morphine, morphine was administered to animals 
pretreated with parachlorophenylalanine (pCP A) . PCP A, a deple-
tor of central and peripheral 5-HT SO, was administered intraper-
itoneally (100 mg/kg/day) for 3 days prior to the experiment .. 
This dosage schedule has been reported to greatly reduce spinal 
levels of 5-HT without altering catecholamine levels SO. The re-
sults from two such ·experiments are shown in Fig .. 4. Depletion 
of centralS-HT did not affect the ability of morphine to depress 
evoked sympathetic activity.. Both spinal reflex (F ig. 4A) and 
intraspinal responses (Fig. 4B) were rapidly reduced to levels 
normally achieved with these doses of morphine. Similarly, PCPA 
pretreatment did not hamper naloxone reversal of the morphine-
induced depression.. In fact, it appeared that r~loxone reversal 
was not only more rapid but also produced a greater enhancement 
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Qf responses above control values than was usually observed in 
, cats not treated with PCPA. Acute depletion of central monoamines 
with reserpine (10 mg/kg) also failed to modify the actions of 
morphine or its antagonism by naloxone. These experiments in-
dicate that morphine-induced depression of sympathetic pregan-
glionic neurons and its antagonism by naloxone are not dependent 
on intact 5-HT stores. 
Tolazoline. The drug tolazoline, a 5-HT and a-adrenergic 
receptor antagonist in the periphery 32, 67, also has been found to 
block the inhibitory 5 - HT receptors on sympathetic preganglionic 
neurons 28.. In a series of five experiments tolazoline was tested 
for its ability to antagonize the effect of morphine on evoked sym-
pathetic discharges. Tolazoline HCl (15-45 mg/kg) proved effec-
tive in both preventing (Fig. 5A) and reversing (Fig. 5B) the 
morphine-induced depression of either pathway. Although tolazo-
line consistently antagonized the depressant effect of morphine, 
the reversal was less rapid than that usually seen with naloxone. 
5-HTP. The serotonin precursor, 5-HTP, produces an im-
mediate and sustained depression of sympathetic preganglionic 
neurons 28,34,66. The depression following 5-HTP has been 
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shown to depend on its conversion to 5-HT and subsequent leakage 
from the serotonin terminals adjacent to these sympathetic 
28, 66 Th . f hO b 1 1° °d d neurons . e antagomsm 0 morp Ine y to azo Ine provi e 
presumptive evidence of a 5-HT-like action for this narcotic anal-
gesic. It was reasoned, therefore, that if morphine stimulates 
5 - HT inhibitory receptors in this system, then naloxone should 
similarly oppose the depressant effect of 5 - HT . 
Two representative spinal reflex experiments are shown in 
Fig. 6 e When given during the depression produced by 5-HTP 
(Fig. 6A), naloxone reveresed the depression and returned the 
size of evoked responses to control levels. Naloxone, given prior 
I 
to 5-HTP (Fig. 6B), prevented the development of depression ty-
pically seen following the administration of this precursor. The 
dashed curves in these figures represent the expected degree and 
duration of inhibition normally produced by the respective doses 
of 5 -HTP. As a rule, somewhat larger amounts of naloxone were 
required for complete antagonism of the 5-HTP-induced depression 
than were required to counteract morphine. Although the onset of 
naloxone reversal of depression by 5-HTP was almost immediate, 
it required 30-40 min for complete antagonism. 
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C1onidine. Clonidine, a drug primarily known for its cen-
trally mediated hypotensive effect, 48,49, 68, 75, 79 , has also been 
reported to possess certain properties in common with the narcotic 
17,69,74,88 
analgesics • The effect of clonidine on activity evoked 
from the sympathetic preganglionic neurons appears to be very 
similar to that of morphine 28. Small doses of clonidine (15 - 25 
Ilg/kg) consistently produced marked depression of both spinal re-
flexes and intraspinally evoked responses. This depression is 
rapid in onset and graded according to dose. Depletion of central 
5-HT 'with PCPA pretreatment does not prevent this effect. Tola-
zoline, however, is an effective antagonist against the actions of 
clonidine in this system 28. Based on these previous observations 
it was concluded that clonidine depresses the sympathetic outflow 
~ 
by stimulation of inhibitory 5 - HT receptors on the sympathetic 
preganglioniC neurons 28. Therefore, the ability of naloxone to 
antagonize clonidine-induced depression was assessed. Results 
from a series of six experiments demonstrated that naloxone (20-
40 Ilg/kg) was capable of oppos ing the action of clonidine on evoked 
sympathetic activit)' Naloxone given immediately before the admin-
istration of c10nidine preve.nted the expected reduction in evoked 
21 
activity. Intraspinally evoked responses which were usua.lly de-
pressed by c lonidine for more than 3 hrs could be restored to 
control levels by naloxone at any stage of the depression (Fig. 7). 
The rate of reversal was similar to that seen against morphine 
but the amount of naloxone needed was usually slightly greater 
than that required for the antagonism of a comparable degree of 
morphine -induced depression. 
Chlorprolnazine. Naloxone alone or during the course of 
reversing morphine-induced depression frequently increased 
evoked sympathetic discharges above control values. Although 
observed in more than a dozen experiments, naloxone did not 
consistently produce this effect. The augmented responses fol-
lowing naloxone reversal of morphine appeared to be unrelated 
to either the degree or duration of the depression. On a number 
of occasions in which naloxone was given first and no enhance-
ment occurred, subsequent challenge with a depressant dose of 
morphine showed that the naloxone blockade was effective. The 
lack of correlation between the appearance of this excitation and 
the naloxone antagonism of morphine suggested that naloxone may 
exert additional effects on the sympathetic preganglionic neurons 
22 
apart from its morphine blocking action. Therefore, further 
characterization of the naloxone actions on these neurons was 
undertaken. 
Chlorpromazine HCl (CPZ), a peripheral and central cate-
cholamine receptor antagonist 1, 94, has been shown to block the ex-
citatory catecholamine receptors on sympathetic preganglionic 
28 34 66 . 
neurons ' , ., Naloxone enhancement of sympathetIc respon-
ses evoked through the spinal reflex pathway was rapidly blocked 
by CPZ at doses of 5-8 mg/kg (Fig. SA). This blockade was ef-
fective immediately and lasted for several hours. Although 
capable of antagonizing the naloxone excitatory effect, further 
investigation showed that epz did not influence either the morphine-
induced depression or the ability of naloxone to reverse that 
depression (Fig. 8B).. These data demonstra te conclusiveJy that 
this excitation, which may be mediated through the catecholamine 
component of the sympathetic preganglionic neuron system, involves 
an action of naloxone separate from its ability to antagonize mor-
phine. 
DISCUSSION 
Morphine can produce bizarre motor and behavioral effects 
in cats at doses greater than 4 mg/kg; below this dose, morphine 
produces typical sedative and analgesic effects 62. The present 
experiments demonstrate that in spinal cats, morphine, at 
0.5-2 mg/kg, produces a prolonged depression of activity evoked 
from sympathetic preganglionic neurons. This effect occurs 
rapidly and persists for at least 5 1/2 hr. The depression by 
morphine appears to be specific since the depression can be antag-
onized by very low doses of naloxone or nalorphine. Demonstra-
tion of identical patterns of depression by three other narcotic 
analgesics and their antagonism by naloxone indicate that this 
effect is not peculiar to morphine but represents an action common 
to this class of drugs. The degree of depression produced by the 
narcotic analgesics was routinely significant, but exhibited some 
variability among experiments. However, their relative potency 
for producing comparable depression of preganglionic neurons 
(morphine, 1 mg/kg; methadone, 1 mg/kg; meperidine, 10 mg/kg; 
codeine, 12 mg/kg) is equivalent to their relative anagesic poten-
cy53, 65. Dextromethorphan, a nonanalgesic stereoisomer related 
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to levorphanol t produces only a limited and nonspecific depression 
of evoked sympathetic activity; the particular characteristics of 
this effect indicates an action different from that of morphine and 
related drugs. 
The observed effects of the narcotic analgesics on activity 
evoked from sympathetic preganglionic neurons generally fulfill 
the criteria for defining useful opiate analges ic models 31. The 
identical effects of four narcotic analgesiCS, their relative potency 
ratios, the rapid and specific antagonism by naloxone and nalor-
phine, and the evidence for stereospecificity indicate that these 
neurons are a potentially useful neuronal system for studying the 
central actions of the narcotic analgesics. Furthermore, the in-
volvement of monaminergic neurons in this system presents the 
possibility of evaluating their role in the central actions of these 
drugs . 
Bulbospinal 5-HT and NE neurons terminate adjacent to the 
sympathetic preganglionic neurons in the lateral columns of the 
thoracic spinal cord 16, 29, 95. Physiological and pharmacological 
evidence indicates that these monoaminergic neurons exert oppo-
site effects on spinal sympathetic neurons, 5 -HT being inhibitory 
25 
28,34,66 
and NE being excitatory . In the present study, discharg-
es from this pool of spinal neurons were evoked through two 
separate pathways. Transmission through the intraspinal pathway 
involves the descending NE neurons 28, 66 whereas the spinal 
reflex pathway contains no monoaminergic neurons 16. Although 
these two pathways both terminate with the sympathetic pregangli-
onic neurons, the actions of drugs at monoaminergic synapses 
affect these pathways differently. For example, blockade of NE 
syn~pses interrupts transmission through the intraspinal pathway 
but leaves the spinal reflex pathway intact28 , 34, 6~ On the other 
hand, activation of 5 - HT receptors, either through the release of 
. 5 HT 34,66 b dO .. 28 presynaptlc - or y a lrect postsynaptlc action pro-
duces inhibition of both pathways. 
Of the known monoaminergic influences impinging upon evoked 
spinal sympathetic discharges, the only action of morphine that is 
consistent with its ability to depress both pathways is activation of 
inhibitory 5 -HT receptors on sympathetic preganglionic neurons 
either directly or indirectly through release of 5-HT. In addition 
to the classical narcotic antagonists, tolazoline was also found to 
be an effective antagonist of morphine on these neurons. Although 
26 
tolazoline is generally regarded as a peripheral a-adrenergic 
receptor blocking agent 67, it also antagonizes 5-HT both in the 
periphery 32 and on spinal sympathetic neurons 28. However, the 
tolazoline blockade of morphine cannot distinguish between a pre-
synaptic or postsynaptic site of action. The failure of 5- HT deple-
tion to alter the ability of morphine to depress evoked sympathetic 
activity indicates that morphine does not cause release of 5-HT 
but strongly suggests that morphine directly stimulates inhibitory 
5-HT rere.ptors in this system. The observations that naloxone 
antagonizes the depressant effects of both 5 - HTP and clonidine, 
two agents that also appear to produce stimulation of inhibitory 
5 -HT receptors on thes e neurons 28, further strengthens this con-
elusion. Full understanding of the anatomy, physiology and bio-
chemistry of the spinal sympathetic neurons is incomplete. Con-
sequently, the possibility that morphine acts through some as yet 
unidentified process cannot be totally excluded, nor can the unlike-
ly possibility be ruled out that morphine depresses the two path-
ways by different mechanisms. However, the most direct inter-
pretation of the available evidence points to a site of action on 
sympathetic preganglionic neurons that strongly resembles the 
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the postsynaptic inhibitory 5 - HT receptors and is cons istent with 
the hypothesis of a direct action on those receptors. No precise 
explanation can be given for the greater sensitivity of the intra-
spinal pathway than of the spinal reflex pathway to morphine. 
However, the same phenomenon has been observed for depression 
of these pathways by clonidine 28 and may represent differences 
in the positional relationship between the locations of the 5 - HT 
receptors and the respective terminations of the two excitatory 
pathways. 
Naloxone rapidly and reversibly blocks the morphine- induced 
depression of sytnpathetic preganglionic neurons in the microgram 
dosage range. Based on these observations and on a considerable 
amount of other available evidence, the naloxone antagonism of 
morphine is most likely a result of direct competition at the mor-
phine receptor, which in the present system appears to be an in-
hibitory 5-HT receptor; the ability of naloxone to antagonize the 
effects of 5-HTP and clonidine on these neurons also strongly sup-
ports this probability. Although the naloxone blockade of 5-HTP-
induced depression could conceivably result from a presynaptic 
action, no such mechanism can account for naloxone reversal of 
28 
the depression by clonidine. The slightly greater amounts of 
naloxone needed to reverse the depressant effects of 5-HTP and clo-
nidine than needed to antagonize morphine may reflect slight dif-
ferences in affinity of these agents for the 5- HT receptors. The 
less rapid antagonism of the effect of 5-HTP by naloxone may in-
dicate a greater specificity of the antagonist against compounds 
with related molecular structures. Aside from these small quan-
titative differences, the mechanisms for naloxone antagonism of 
5-HTP, clonidine, and the narcotic analgesics all appear to be 
qualitatively identical. 
In addition to its ability to block the effect of narcotic anal-
gesics on sympathetic preganglionic neurons, naloxone frequently 
produces increases in evoked activity. The relative irregularity 
in the appearance of this secondary effect when contrasted against 
the regularity with which naloxone antagonized the effect of mor-
phine rules out the possibility that naloxone stimulation of pre-
ganglionic neurons is responsible for its antagonism of morphine-
induced depression. Furthermore, chlorpromazine can block this 
excitation without affecting the ability of naloxone to reverse the 
depression by morphine. Excitation following the administration 
29 
of narcotic antagonists either alone or in the course of antagoniz-
ing narcotic depression has been reported frequently in both 
clinical and experimental situations, and several authors have 
noted the irregularity of its appearance 25,44,46,55,58,59, 61 • 
The rapid blockade of naloxone- induced excitation by chlorproma-
zine indicates that this effect is mediated through the excitatory 
NE input to the sympathetic preganglionic neurons 28,34, 66. If 
the excitation was due to direct stimulation of NE receptors, then 
evoked sympathetic responses should have been increased in 
. 28 34 66 
every experIment ' , . However, a presynaptic action de-
pendent upon some residual catecholamine leakage from decen-
tralized NE terminals in some experiments could account for the 
irregular appearance of the excitatory effect. Indeed, blockade of 
synaptosomal NE reuptake by naloxone has been demonstrated 
in vitro 12. To the degree that this secondary effect is present, 
the capacity to stimulate sympathetic neurons in addition to its 
direct morphine blocking action suggests that naloxone may act as 
a physiological antagonist as well as a pharmacological antagonist 
of narcotic analgesics in this system. 
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Interpretation of the respective roles of catecholamine and 
5-HT systems in the acute central effects of the narcotic ana1ge-
sics is controversial. Many studies are available, but large var-
iations in the doses of narcotics and antagonists used, species 
differences, and the diverse methods employed for assessing the 
acute effects all combine to make reconciliation of conflicting 
interpretations very difficult. Evidence is available to suggest 
that central NE mechanisms either may mediate 51, 73, 80, 85 or 
may antagonize 8, 9, 64, 78, 84 the effects of morphine and other 
narcotic analgesics. With regards to 5-HT, some investigators 
have found that decreasing central 5-HT tone does not influence 
h · . d d 1 ,6, 38, 60, 91 h'l hi' acute morp Ine-In uce ana gesia w I e ot ers calm 
that analgesia does require functional 5-HT neurons or that 5-HT 
d h ' d dd' . l' ff 70, 71, 72, 90 Th an morp Ine pro uce a Itive ana gesic e ects . e 
sympathetic preganglionic neurons almost certainly play no dir-
ect role in mediating nociception, but, insofar as these neurons 
can serve as a central model, the present results may help to re-
solve these controversies. Some caution should be used when 
comparing results from whole animal studies with those of the 
present study ~n which spontaneous bulbospinal 5 -HT tone has 
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been compromised by spinal transsection. Nevertheless, in 
light of the apparent 5-HT agonist action of morphine on sympa-
thetic preganglionic neurons, it can be suggested that morphine 
could augment centralS - HT activity in the intact animal, in 
which case PCPApretreatment might appear to reduce the effect 
of morphine whereas activation of 5 - HT activity might appear to 
enhance the effect of morphine. 
A number of investigators have concluded that reactions 
to nociceptive stimuli and their alterations by the narcotic anal-
gesics are dependent not on a single monoamine but on the rela-
. 77 78 84 86 tlve balance of several endogenous compounds ' , , . 
Takemori et al. 86 have classified the 5-HT system as a pos-
itive modulator and the dopaminergic system as a negative mod-
ulator of the analgesic action of morphine. The observations 
that 5-HT markedly potentiates whereas NE attenuates the ac-
tions of narcotic analgesics have led others to suggest that the 
-
central effects of these drugs are intimately involved with opposed 
5 HT d NE 8,9,77,78,84 S' h h . - an systems . Ince t e sympat etlc pre-
gangliOniC neurons are inhibited by 5-HT and excited by NE28, 34, 66, 
the present demonstration that they are also inhibited by morphine is 
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consistent with the hypothes is that 5 - HT systems are synergistic 
with its central actions. The lack of dopamine terminals in the 
spinal cord curtail any judgment on its role in the actions of 
morphine. The ability of NE to excite preganglionic neurons, 
however, presents a provocative example supporting contentions 
that noradrenergic activity opposes the central effects of the nar-
cotic analges ics . 
Morphine and other narcotics depress cardiovascular function 
through an action at both central and peripheral sites 20, 21, 22, 58 . 
The inhibition of central cardiovascular structures that contri-
butes to reduction in blood pressure, heart rate and sympathetic 
. . b bl k db· . 18,20,54,58 h actIvIty can e oc e y narcotic antagonIsts , sows 
rapid development of tolerance 7,58 and appears to be involved in 
some of the manifestations of dependence and withdrawal 58 . A 
medullary site mediating this central inhibition has been suggest-
ed 7,18, 21,54, but an action at the spinal level has not been exclud-
ed 54 . Since the sympathetic preganglionic neurons are the final 
central units for integrating sympathetic outflow and vasomotor con-
trol, inhibition of these neurons may account for the central com-
ponent of narcotic-induced depression of cardiovascular tone. This 
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explanation is consistent with the observations that 5- HT precur-
sors and clonidine, both of which produce vasodepression 2,3,43, 
49, 68 and inhibition of sympathetic outflow 4,39,56, also. de-
press spinal sympathetic neurons 28, 34,66. Although depression 
of these spinal neurons may be sufficient to account for the central-
ly mediated hypotension, demonstrations by other investigators 
that supraspinal cardiovascular centers are inhibited by narcot-
18,21, 54 fcs indicate actions at several levels along the neuraxis. 
Although the present study was concerned only with the 
acute actions of the narcotic analgesics on the sympathetic pre-
ganglioniC neurons, the unequivocal results prompt some specu-
lation about the chronic effects of these agents on eNS activity. 
In addition to spinal integration of sympathetic outflow, other 
central systems may fWIction under reciprocal catecholamine 
and 5-HT control. For example, these putative transmitters have 
been shown to produce opposite effects on the central control of 
motor rhythmicity 89, respiration 24,25, sleep63, certain as-
peets of animal behaviorS, 30, 57, 92 and temperature regula-
. 40 
tlon 0 The normal functioning, adjustments and derangements 
of such central systems may reflect changes in balance between 
34 
opposing monoaminergic influences rather than isolated changes 
in the activity of a single element. Responses to disturbances in 
functional balance and the reestablishment of centrally controlled 
homeostasis required by the presence of a narcotic analgesic have 
been offered as explanations for the phenomena of tolerance, 
d d d · hd 115, 36, 47 epen ence an WIt ra wa . Depression of the autono-
mic nervous system by administration of the narcotic analgesics 
d " d' h f' 7,36 lsappears urlng t e course 0 contInuous treatment • If, 
following the development of tolerance, drug treatment is discontin-
ued, narcotic withdrawal with overt manifestations of sympathetic 
h .. d 1 36,45 yperactlvlty eve op . 
Both c10nidine and 5 - HT, which acutely depress the excita-
bility of sympathetic preganglionic neurons, also share other 
properties with the narcotic analgesics. Precursors of 5 -HT pro-
duce vasodepression and inhibition of sympathetic outflow 2, 3, 4, 23 . 
Continuous administration of 5 - HTP produces tolerance to many of 
its central actions, and abrupt withdrawal produces signs of sym-
pathetic activation 93. Clonidine, a centrally acting drug used for 
anti--hypertensive therapy, also has been shown to possess both 
anti-nociceptive and sedative properties 17,19,68,69,74. In 
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addition, clonidine can antagonize some of the manifestations of 
1 .. d . hd 1 f ... 1 88 na oxone precipitate Wit rawa rom narcotIcs In anIma s , 
and abrupt discontinuance during chronic therapy can produce ab-
stinence signs similar in many respects to those seen during 
narcotic withdrawal 33, 39. Therefore, it appears that prolonged 
exposure to clonidine or 5 - HT precursors can produce forms of 
both tolerance and dependence that are similar to those produced 
by narcotic analgesics. 
Whether continuous stimulation of inhibitory 5- HT recep-
tors could elicit an increase in noradrenergic activity to balance 
the depression and thereby lead to the reduced narcotic effect is 
hypothetical, but considerable evidence is available to suggest 
this possibility. A number of studies have shown that chronic 
administration of narcotic analgesics does cause an increase in 
central norepinephrine turnover 14, 17, 80, 83 e A lessening of some 
of the symptoms of narcotic withdrawal has been achieved either 
by decreasing central noradrenergic stores 35, 76 or by admin-
istering the catecholamine antagonists g chlorpromazine or phen-
oxybenzamine 11 . Increasing the levels of central catecholamines, 
however, augments certain manifestations of withdrawal 35 . 
36 
Enhanced development of tolerance and intensified withdrawal can 
also be achieved by raising central levels of cyclic adenosine 
monophosphate 15, 26,37; this observation takes on added signifi-
'cance from recent evidence that this cyclic nucleotide mediates 
81,82 
the central postsynaptic actions of NE e If an increase in 
central NE tone response to continuous narcotic - induced inhibition 
is responsible for the development of tolerance, the augmented 
NE excitatory tone might also account for the increase in central 
activity seen upon withdrawal. 
The development of an endogenous mechanis m oppos ing the 
actions of narcotic drugs could also account for the development 
of latent hyperexcitability in which decreasing amounts of antago-
nist are required to precipitate a withdrawal reaction as tolerance 
44 87 increases' "In response to a sustained narcotic-induced de-
pression and in an effort to reestablish functional homeostasis, 
excitatory neuronal components (perhaps NE neurons in the spinal 
sympathetic system) may gradually increase their activity above 
normal levels .. Termination of the narcotic action, either by with-
drawing the drug or by displacing it from opiate receptors would 
unmask the enhanced excitatory activity. As the opposing 
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excitatory tone progressively increases to enhance the level of 
tolerance, it would require lessening amounts of antagonist to 
precipitate a withdrawal reaction because the excitatory system 
would be operating at progressively higher levels. Considered in 
this context, equivalent partial displacement of narcotic analgesics 
molecules from their receptors by an antagonist would precipitate 
greater withdrawal reactions in highly tolerant subjects than in 
subjects with lower levels of tolerance. An intriguing observa-
tion of the present study was the ability of naloxone not only to block· 
the narcotic action but frequently to increase the excitability of 
sympathetic preganglionic neurons, apparently by augmenting the 
NE tone to these cells. 
Although the findings of this study pertain only to the acute 
actions of narcotic analgesics and the suggestions for their long-
term effects are only speculative, they are in agreement with 
the observations of many other investigators and they do form a 
basis for testable hypotheses to explain a number of the central 
effects of these drugs. 
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Fig. 1. Schematic representations of the two pathwa ys used for 
evoking sympathetic preganglionic neuron (SPGN) discharges. 
A, Stimulation of small myelinated afferent fibers in adjacent in-
tercostal nerves evokes SPGN discharges through the polysynaptic 
spinal reflex pathway. B, Stimulation with bipolar microelectrodes 
positioned in the dorsolateral funiculus of the cervical spinal cord 
evokes SPGN discharges through the intraspinal pathway. Dis-




















Fig. 2. Effects of morphine and naloxone on transmission through 
spinal reflex and intraspinal pathways. A, Morphine-induced re-
duction in spinal sympathetic reflex and its antagonism by naloxone. 
Activity was evoked by stimulating T2 intercostal nerve and record-
ed from T4 preganglionic ramus. B, Morphine-induced depression 
of intraspinally evoked responses (recorded from T2 ramus) and its 
antagonism by naloxone. Representative traces are shown for each 
phase (C, control; M, morphine; and N, naloxone) of the two exper-
iments. Upper traces are individually evoked responses; lower 
traces represent computer averages of 32 (spinal reflex) or 16 
(intraspinally evoked) consecutive responses. Calibrations: ver-
tical, 40 ~V in A, 100 JlV in B; horizontal, 20 msec in both. Graphs 
below show time courses of the respective experiments; individual 
points were calculated from computer averages. Dashed lines in-
dicate + 2 Standard Deviations (S.D.) of the mean control value ob-












































































































































































Fig. 3. Rapid depression of intraspinally evoked responses by 
methadone (A), meperidine (B), and codeine (C) and antagonism 
59 
by naloxone. Limited depression by dextromethorphan (D) is unre-
sponsive to naloxone. Pyrilamine was given in D to prevent the 
severe vasodepressor effect of dextromethorphan. Dashed lines 






















































































































































































Fig. 4. Morphine-induced depression of evoked sympathetic dis-
charges and naloxone reversal after pretreatn1ent with parachloro-
phenylalanine (pCPA, 100 mg/kg/day, i.p., for 3 days prior to the 
day of the experiment). Pretreatment did not alter the depressant 
effect of morphine or its reversal by naloxone in either the spinal 
reflex (A) or the intraspinally evoked response (B). Dashed lines, 


















































































































































Fig. 5. Antagonism of morphine-induced depression by tolazoline. 
A, Prevention of morphine-induced depression of spinal sympathe-
tic reflexes by tolazolme. B, Reversal of morphine-induced de-
pression of intraspinally evoked responses by tolazoline . Dashed 






















































































































Fig. 6. Antagonisnl (A) and prevention (B) of 5 -HTP-induced de-
pression of spinal sympathetic reflexes by naloxone. Dashed curves 










































































































































































Fig .. 7. Antagonism by naloxone of clonidin,e-induced depression 
of intraspinally evoked responses. Dashed curve represents the 














Fig. 8. Effects of chlorpromazine (CPZ) on the actions of nalo-
xone and morphine in the spinal reflex pathway. A, Rapid antago-
nism of naloxone enhancement of spinal reflex discharges by CPZ. 
B, Morphine-induced depression of evoked activity and its reversal 














































































































Kevin Lee McCloskey 
Riverside, California 
October 31, 1943 
Notre Dame High School 
Riverside, California 
Saint Mary's College 
Moraga, California 
Univers tty of Utah 
Salt Lake City, Utah 
B.S., Saint Mary's College 
Moraga, California 
American Association for 
the Advancement of Science, 
American Academy of 
Forensic Sciences, Sigma Xi, 
California Ass ociation of 
TOxicologists 
McCloskey, K. L., Muscillo, G. C., and Noordewier, B., 
Prostatic acid phosphatase activity in the post-coital vagina, 
Journal of Forensic Sciences, 20 (1975) 630-636. 
Finkle, B. S., McCloskey, K. L., Kiplinger, G., and 
Bennett, I., A national ass essment of propoxyphene in post-




McCloskey, K. L., and Franz, D. N., Effects of LSD, 
mescaline and psilocybin on sympathetic preganglionic neu-
rons, The Pharmacologist, 16 (1974) p .237 . 
McCloskey, K. L., Franz, D. N., Hare, B. D., and Neu-
rna yr, R. J., Effects of morphine and naloxone on sympa-
thetic preganglionic neurons, The Pharmacologist, 17 (1975) 
p. 188. 
Franz, D. N., Hare, B. D., McCloskey, K. L., and Neu-
mayr, R. J., Effects of morphine on sympathetic outflow, 
Abstracts of Scientific Papers, American Society of Anesthe-
siologists, (1975) p. 169. 
